NCT04654208View on ClinicalTrials.gov

Swedish Ibrance Registries Insights (SIRI)

RecruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions

Malignant Neoplasm of Breast

Interventions

DRUG

palbociclib

patients on palbociclib combination treatment

Trial Locations (1)

Unknown

RECRUITING

Pfizer AB, Sollentuna

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY